Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapiesElena Ardini,Salvatore SienaESMO Open(2020)引用 15|浏览1暂无评分关键词entrectinib,NTRK inhibitor,ROS1 inhibitor,cancer therapyAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要